Press Releases

Filters
July 24, 2006

Debiopharm applies for first europe marketing authorisation for Sanvar® in France

Read more
June 27, 2006

Debiopharm and Aurigene enter into an Agreement to identify and develop selective compounds for immuno-oncology targets

Read more
June 20, 2006

Moapar® 3-months approved for the lowering of testosterone to castrate serum levels for control of sexual drive in adult men

Read more
June 14, 2006

The Debiopharm Group and Sigma-Tau sign R&D and commercial agreement for Istaroxime in acute heart failure syndromes

Read more
June 1, 2006

The Debiopharm Group to initiate confirmatory phase III trial for Sanvar® in esophageal variceal bleeding

Read more
May 22, 2006

Debiopharm and TcLand sign R&D and exclusive license option for the development of sc28AT autoimmune diseases and transplantation

Read more
May 2, 2006

Debiopharm et la Haute Ecole Valaisanne collaborent pour développer les médicaments de demain

Read more
April 25, 2006

Debiopharm presents phase I monthly implant and phase II daily oral results of ZT-1 for Alzheimer´s disease

Read more
February 9, 2006

Debiopharm S.A. presented results of a double-blind placebo-controlled study on first-in-class Debio-025 in HIV-1-infected subjects

Read more